Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel. [electronic resource]
- Cancer chemotherapy and pharmacology Nov 2006
- 640-53 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0344-5704
10.1007/s00280-006-0214-9 doi
ATP Binding Cassette Transporter, Subfamily B, Member 1--antagonists & inhibitors Animals Antineoplastic Agents, Phytogenic--pharmacology Antineoplastic Combined Chemotherapy Protocols--therapeutic use Blotting, Western Breast Neoplasms--genetics Cell Line, Tumor Dose-Response Relationship, Drug Doxorubicin--administration & dosage Drug Resistance, Multiple--drug effects Drug Resistance, Neoplasm--drug effects Female Gene Expression--drug effects Humans Masoprocol--administration & dosage Mice Mice, Nude Monosaccharides--administration & dosage Paclitaxel--administration & dosage RNA, Messenger--genetics Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays--methods